http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103989676-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-436 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12 |
| filingDate | 2014-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103989676-B |
| titleOfInvention | The CCI-779 compositions of injectable |
| abstract | The present invention relates to the CCI-779 compositions of a kind of injectable。Specifically, on the one hand, the present invention relates to a kind of composition of liquid medicine, wherein comprise: CCI-779, dehydrated alcohol, organic acid and propylene glycol etc.。On the other hand, the present invention relates to a kind of acceptable diluent, wherein comprise polyoxyethylene sorbitan monoleate, dehydrated alcohol and PEG400。Another further aspect, the present invention relates to a kind of medicine, including fluid present invention pharmaceutical composition and the acceptable diluent of the present invention of subpackage respectively。Fluid present invention pharmaceutical composition and medicine thereof can be used for the treatment of tumor such as advanced renal cell carcinoma。 |
| priorityDate | 2014-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 256.